These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1514136)

  • 1. [Granulocyte alkaline phosphatase activity in the chronic phase and blastic crisis of chronic myeloid leukemia. Sequential study of 43 patients].
    Bosch F; Cervantes F; Rozman M; Terol MJ; Montserrat E; Rozman C
    Sangre (Barc); 1992 Aug; 37(4):245-7. PubMed ID: 1514136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cause of death, survival, and prognostic factors in a series of 98 patients with chronic myeloid leukemia].
    Jonte F; Fernández-Fuertes F; Cecchini C; Luño E; Ordóñez A; Fernández C; Suárez P; Lausín A; Fernández J
    Sangre (Barc); 1992 Oct; 37(5):351-4. PubMed ID: 1293774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in serum RNase activities in chronic phase and acute crisis of chronic myelocytic leukemia].
    Maruoka K; Yamanaka M; Misago M; Nakata K; Tsukada J; Nagata K; Sato T; Mori N; Oda S; Chiba S
    Rinsho Ketsueki; 1989 Jul; 30(7):988-93. PubMed ID: 2810801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].
    Liu XL; Zhou SY; Du QF; Zheng WY; Zhang S; Song LL; Xu B; Liu QF; Meng FY
    Ai Zheng; 2004 Apr; 23(4):421-5. PubMed ID: 15087031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sudden onset of the blastic phase of chronic myelogenous leukemia: patterns and implications.
    Kantarjian H; O'Brien S; Cortes J; Giles F; Thomas D; Kornblau S; Shan J; Beth Rios M; Keating M; Freireich E; Talpaz M
    Cancer; 2003 Jul; 98(1):81-5. PubMed ID: 12833459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Causes of death in chronic myeloid leukemia. Analysis of 109 patients].
    Cervantes F; Sanz C; Bosch F; Rozman C
    Sangre (Barc); 1991 Jun; 36(3):183-6. PubMed ID: 1948535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breakpoint cluster region, immunoglobulin, and T-cell receptor gene rearrangement analysis in juvenile chronic myelogenous leukemia.
    Farhi DC; Luckey CN; Siddiqui AM
    Mod Pathol; 1995 May; 8(4):389-93. PubMed ID: 7567936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leucocyte alkaline phosphatase identifies terminally differentiated normal neutrophils and its lack in chronic myelogenous leukaemia is not dependent on p210 tyrosine kinase activity.
    Dotti G; Garattini E; Borleri G; Masuhara K; Spinelli O; Barbui T; Rambaldi A
    Br J Haematol; 1999 Apr; 105(1):163-72. PubMed ID: 10233380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic myelogenous leukemia in the lymphoid blastic phase: characteristics, treatment response, and prognosis.
    Derderian PM; Kantarjian HM; Talpaz M; O'Brien S; Cork A; Estey E; Pierce S; Keating M
    Am J Med; 1993 Jan; 94(1):69-74. PubMed ID: 8420302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idarubicin in blastic crisis of chronic myelogenous leukemia.
    Lambertenghi-Deliliers G; Annaloro C; Cortellaro M; Pozzoli E; Oriani A; Polli EE
    Haematologica; 1991; 76(5):406-8. PubMed ID: 1806446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Blast crisis of chronic myeloid leukemia with positive Philadelphia chromosome: course and clinico-hematologic profile in 80 patients].
    Cervantes F; Rozman M; Salgado C; Vives-Corrons JL; Montserrat E; Rozman C
    Med Clin (Barc); 1990 May; 94(18):681-4. PubMed ID: 2388491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic myeloid leukemia: correlation between purine metabolism enzyme activities and membrane immunophenotype.
    Mesárosová A; Hrivnáková A; Klobusická M; Babusíková O
    Neoplasma; 1995; 42(1):9-14. PubMed ID: 7617076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients.
    Maxwell SA; Kurzrock R; Parsons SJ; Talpaz M; Gallick GE; Kloetzer WS; Arlinghaus RB; Kouttab NM; Keating MJ; Gutterman JU
    Cancer Res; 1987 Mar; 47(6):1731-9. PubMed ID: 2434223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
    Okabe M
    Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of programmed cell death proteins in patients with chronic myeloid leukemia.
    Strnad M; Brajuskovic G; Strelic N; Todoric-Zivanovic B; Stamatovic D; Tatomirovic Z; Magic Z
    J BUON; 2008; 13(3):403-8. PubMed ID: 18979557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Extramedullary blast crisis in chronic myeloid leukemia].
    Cervantes F; Rozman M; Nicolás JM; López Guillermo A; Rozman C
    Sangre (Barc); 1989 Apr; 34(2):96-8. PubMed ID: 2756456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Features of chronic myeloid leukemia at diagnosis. Study of a series of 134 cases].
    Jonte F; Barez A; Soto I; Rayón C; Carrera D; Coma A; Pérez Llanderal J; Arribas M
    Sangre (Barc); 1992 Oct; 37(5):345-50. PubMed ID: 1293773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated and blastic phases of chronic myelogenous leukemia.
    Giles FJ; Cortes JE; Kantarjian HM; O'Brien SM
    Hematol Oncol Clin North Am; 2004 Jun; 18(3):753-74, xii. PubMed ID: 15271404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac tamponade in the blastic crisis of chronic myelogenous leukemia.
    Yamauchi K; Arimori S; Nagao T
    Tokai J Exp Clin Med; 1992 Jul; 17(2):89-93. PubMed ID: 1440659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.